All Hands on Deck for Fill/Finish of Vaccines and Therapeutics

“Emergent has a long, successful history of working with the US government to develop, manufacture, and deliver safe and effective medical countermeasures for public health. BARDA has been an excellent partner, across all levels from leadership to the project and technical teams with whom we work closely. As partners on a team, we work collaboratively to monitor, evaluate, and progress projects and help remove barriers that slow down the directive of Operation Warp Speed.”

Dino Muzzin, senior vice president of manufacturing operations at Emergent BioSolutions contributed to an editorial in the August issue of Pharmaceutical Technology on the pivotal role outsourcing partners have in the rapid development and production of COVID-19 vaccine candidates. 

Read the full article here

Article Details

Pharmaceutical Technology
Supplement: Outsourcing Resources
August 2020
Pages: s15–s17

Citation

J. Markarian, “All Hands on Deck for Fill/Finish of Vaccines and Therapeutics," Pharmaceutical Technology Outsourcing Resources Supplement (August 2020).

Ondemand Webinar: HIGH-SPEED MANUFACTURING FOR YOUR VIRAL VACCINE OR THERAPEUTIC

Our viral drug product manufacturing facility in Rockville, MD is home to our INTEGRA® high-speed bulk filling line, with fully...

READ MORE

Ondemand Webinar: MANUFACTURING NEXT-GEN THERAPIES  - THE VANRX SA25 ASEPTIC FILLING WORKCELL

Our state-of-the-art Vanrx® SA25 Aseptic Filling Workcell can be deployed to support your clinical or commercial drug product...

READ MORE

Ondemand Webinar: ENHANCING OUR CAPABILITIES FOR ASEPTIC FILL / FINISH PROCESSING

Watch our latest webinar on the topic of aseptic fill/finish and isolator-based technology for pre-sterilized syringes,...

READ MORE